Ascendis Pharma A/S

ASND DKK1
Create an alert
Sell$260.00
Buy$266.00
$2.29 (0.87%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 September 2026
Mads BodenhoffChief Accounting Officer
Sell
Option/Award related
3,000$270.19$810,570.000
2 September 2026
Lars HoltugDirector
Sell
Regular sell transaction (market)
236$264.13$62,334.594,000
14 August 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
900$246.91$222,219.002,900
14 August 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
1,100$245.85$270,435.002,000
2 June 2026
Scott Thomas SmithCFO
Buy
Regular purchase transaction
100$219.00$21,900.004,367
29 May 2026
Scott Thomas SmithCFO
Buy
Regular purchase transaction
250$223.32$55,830.004,267
29 May 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
100$223.50$22,350.00900
29 May 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
200$222.30$44,460.00800
29 May 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
200$223.76$44,752.00600
26 May 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
200$239.37$47,873.50400

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
11 May 2026
Flemming Steen JensenExecutive Vice President
Sell
Regular sell transaction (market)
19,460$238.49$4,641,021.240
8 September 2026
Mads BodenhoffChief Accounting Officer
Sell
Option/Award related
3,000$270.19$810,570.000
14 August 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
1,100$245.85$270,435.002,000
14 August 2026
Jean Jacques BienaimeDirector
Buy
Regular purchase transaction
900$246.91$222,219.002,900
2 September 2026
Lars HoltugDirector
Sell
Regular sell transaction (market)
236$264.13$62,334.594,000

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.